What is BioCryst Pharmaceuticals's interest paid?

BioCryst Pharmaceuticals (BCRX) reported interest paid of $6.08M in Q1 2026.

How has BioCryst Pharmaceuticals's interest paid changed year-over-year?

BioCryst Pharmaceuticals's interest paid decreased by 33.5% year-over-year, from $9.15M to $6.08M.

What is the long-term trend for BioCryst Pharmaceuticals's interest paid?

Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's interest paid has grown at a 126.6% compound annual growth rate (CAGR), from $900K to $23.74M.

What does interest paid mean?

Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.

BioCryst Pharmaceuticals BCRX Interest Paid

Interest Paid at other companies

Ionis PharmaceuticalsIONS

$90K-2.2%

BridgeBio PharmaBBIO

$20.32M-12.7%

Arrowhead ResearchARWR

$4.75K—

ALN

Alnylam PharmaceuticalsALNY

$64.2M-6.9%

PrecigenPGEN

$2.56M—

Catalyst PharmaceuticalCPRX

$140K+35.9%

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's interest paid?: BioCryst Pharmaceuticals (BCRX) reported interest paid of $6.08M in Q1 2026.
How has BioCryst Pharmaceuticals's interest paid changed year-over-year?: BioCryst Pharmaceuticals's interest paid decreased by 33.5% year-over-year, from $9.15M to $6.08M.
What is the long-term trend for BioCryst Pharmaceuticals's interest paid?: Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's interest paid has grown at a 126.6% compound annual growth rate (CAGR), from $900K to $23.74M.
What does interest paid mean?: Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.